BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
MediciNova
MNOV
$65M
| $4.79M | ﹤0.01% |
1,127,922
-2,259,671
| -67% | -$9.73M |
|
3802
Goldman Sachs BDC
GSBD
$983M
| $4.79M | ﹤0.01% |
244,157
+25,006
| +11% | +$494K |
|
3803
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.2B
| $4.77M | ﹤0.01% |
108,580
+46,644
| +75% | +$2.03M |
|
|
EARN
3804
Ellington Residential Mortgage REIT
EARN
$162M
| $4.71M | ﹤0.01% |
400,319
-515,180
| -56% | -$6.38M |
|
|
SPRB
3805
Spruce Biosciences
SPRB
$119M
| $4.71M | ﹤0.01% |
5,597
+993
| +22% | +$1.06M |
|
3806
Karat Packaging
KRT
$823M
| $4.71M | ﹤0.01% |
+230,943
| New | +$4.39M |
|
3807
Ovid Therapeutics
OVID
$427M
| $4.7M | ﹤0.01% |
1,202,730
-2,498,958
| -68% | -$9.86M |
|
3808
Bausch Health
BHC
$2.46B
| $4.7M | ﹤0.01% |
160,110
-1,299,915
| -89% | -$39.4M |
|
|
DLA
3809
DELISTED
Delta Apparel Inc.
DLA
| $4.68M | ﹤0.01% |
158,517
-28,202
| -15% | -$863K |
|
3810
Bit Digital
BTBT
$484M
| $4.66M | ﹤0.01% |
+681,976
| New | +$7.27M |
|
3811
TaskUs
TASK
$565M
| $4.65M | ﹤0.01% |
+135,686
| New | +$4.29M |
|
3812
iShares MSCI Malaysia ETF
EWM
$324M
| $4.64M | ﹤0.01% |
181,555
+1,268
| +0.7% | +$34.5K |
|
3813
Pembina Pipeline
PBA
$28.1B
| $4.63M | ﹤0.01% |
145,800
+4,930
| +3% | +$155K |
|
|
CLLS
3814
Cellectis
CLLS
$287M
| $4.56M | ﹤0.01% |
294,869
+99,370
| +51% | +$1.67M |
|
3815
Riley Exploration Permian
REPX
$743M
| $4.56M | ﹤0.01% |
157,336
+144,827
| +1,158% | +$5.16M |
|
|
ACH
3816
DELISTED
Alum Corp of China Ltd
ACH
| $4.55M | ﹤0.01% |
307,892
+29,664
| +11% | +$401K |
|
|
AAIC
3817
DELISTED
Arlington Asset Investment Corp.
AAIC
| $4.54M | ﹤0.01% |
1,118,428
-1,988,334
| -64% | -$8.06M |
|
3818
SLR Investment Corp
SLRC
$698M
| $4.54M | ﹤0.01% |
243,438
+29,643
| +14% | +$556K |
|
3819
Westwood Holdings Group
WHG
$187M
| $4.5M | ﹤0.01% |
206,556
-506,694
| -71% | -$9.63M |
|
|
SFE
3820
DELISTED
Safeguard Scientifics, Inc.
SFE
| $4.49M | ﹤0.01% |
578,872
-1,202,782
| -68% | -$8.2M |
|
3821
Gaia
GAIA
$46.8M
| $4.49M | ﹤0.01% |
408,050
-743,581
| -65% | -$8.44M |
|
|
EWJE
3822
DELISTED
iShares MSCI Japan Equal Weighted ETF
EWJE
| $4.48M | ﹤0.01% |
115,000
| – | – |
|
3823
National Bankshares
NKSH
$265M
| $4.46M | ﹤0.01% |
127,494
-390,689
| -75% | -$13.8M |
|
|
CCC
3824
CCC Intelligent Solutions
CCC
$3.63B
| $4.42M | ﹤0.01% |
443,471
-675,136
| -60% | -$6.81M |
|
|
TBIO
3825
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $4.4M | ﹤0.01% |
+11,109
| New | +$3.93M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.